Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
EdgeOne Venture Partners is a venture capital firm that operates independently from EdgeOne Medical, which was founded in 2012. Based in the United States, EdgeOne Venture Partners focuses on investment opportunities in the biopharmaceutical sector, particularly in the development of complex combination product devices and systems. This separation allows EdgeOne Venture Partners to capitalize on opportunities that EdgeOne Medical historically had to decline due to its consulting focus.
The firm leverages its connection to EdgeOne Medical, which has a strong track record of servicing ten of the top twenty global biopharma firms. This relationship provides EdgeOne Venture Partners with unique insights and access to industry leaders, enhancing its investment strategy. As a relatively new entity, EdgeOne Venture Partners is currently in a program announcement phase, with plans to expand its investment activities in the near future.
EdgeOne Venture Partners invests in the biopharmaceutical sector, targeting both established companies and emerging startups. Their investment strategy encompasses various stages, including seed, Series A, Series B, Series C, and growth equity. The firm emphasizes the development of combination product devices and systems, which are critical in the evolving landscape of biopharmaceutical innovation.
In addition to biopharmaceuticals, EdgeOne Venture Partners is also interested in adjacent sectors such as medtech and digital health. The firm seeks to support innovative solutions that address complex challenges in these fields. Their investment approach is designed to provide significant value to portfolio companies through access to EdgeOne Labs' capabilities, connections to major pharmaceutical companies, and opportunities for partnerships and co-investments.
EdgeOne Venture Partners has not publicly disclosed specific portfolio companies. However, the firm has highlighted its expertise through case studies related to device qualification and design verification and validation testing for biologics and custom devices. These case studies demonstrate the firm's capabilities in supporting biopharmaceutical innovation and the development of combination product devices.
While specific investments remain undisclosed, the firm's focus on complex combination product devices and systems indicates a commitment to supporting companies that are pioneering advancements in the biopharmaceutical sector. This strategic focus positions EdgeOne Venture Partners as a valuable partner for startups aiming to innovate in the healthcare and biotech industries.
Jim McGough - Founding Managing Partner. Jim co-founded EdgeOne Medical and has extensive experience in the biopharmaceutical sector. His background includes leading initiatives in combination product development and providing strategic insights to emerging biotech firms.
As of April 2024, EdgeOne Venture Partners is listed as an exhibitor at the BIO Investor Forum 2024, marking its earliest external footprint as a venture entity. The firm has not yet made any public deal announcements or disclosed specific fund sizes.
What are EdgeOne Venture Partners' investment criteria?
EdgeOne Venture Partners focuses on the biopharmaceutical sector, particularly in the development of combination product devices and systems. They invest in both established companies and emerging startups across various stages, including seed, Series A, Series B, Series C, and growth equity.
How can I pitch to EdgeOne Venture Partners?
Founders interested in pitching to EdgeOne Venture Partners should prepare a detailed presentation that outlines their business model, market opportunity, and how their product aligns with the firm's focus on combination product devices and systems. While specific submission channels are not disclosed, reaching out through their website is recommended.
What makes EdgeOne Venture Partners different from other VC firms?
EdgeOne Venture Partners distinguishes itself through its connection to EdgeOne Medical, which has a strong track record in servicing top global biopharma firms. This relationship provides unique insights and access to industry leaders, enhancing the firm's investment strategy.
What is the geographic focus of EdgeOne Venture Partners?
The firm primarily invests in the United States, targeting opportunities within the biopharmaceutical sector.
What kind of support do portfolio companies receive?
EdgeOne Venture Partners provides significant value to its portfolio companies by offering access to EdgeOne Labs' capabilities, connections to major pharmaceutical companies, and opportunities for partnerships and co-investments in the biopharmaceutical sector.
What is the current status of EdgeOne Venture Partners?
As of now, EdgeOne Venture Partners is in a program announcement phase, with plans to expand its investment activities. They have not yet disclosed specific portfolio companies or fund sizes.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.